These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11119251)

  • 1. No evidence for generation of Th-2-like MBP-specific T-cell lines by blockade of the costimulatory molecule B7-1.
    Zipp F
    Scand J Immunol; 2000 Nov; 52(5):510-4. PubMed ID: 11119251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of costimulatory molecules B7-1 and B7-2 on microglial cells induced by Th1 and Th2 cells in organotypic brain tissue.
    Wolf SA; Gimsa U; Bechmann I; Nitsch R
    Glia; 2001 Dec; 36(3):414-20. PubMed ID: 11746777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy.
    Kuchroo VK; Das MP; Brown JA; Ranger AM; Zamvil SS; Sobel RA; Weiner HL; Nabavi N; Glimcher LH
    Cell; 1995 Mar; 80(5):707-18. PubMed ID: 7534215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of experimental blood stage malaria through blockade of the B7/CD28 T-cell costimulatory pathway.
    Taylor-Robinson AW; Smith EC
    Immunology; 1999 Mar; 96(3):498-504. PubMed ID: 10233733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8+ T cells control the TH phenotype of MBP-reactive CD4+ T cells in EAE mice.
    Jiang H; Braunstein NS; Yu B; Winchester R; Chess L
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6301-6. PubMed ID: 11353822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD28 costimulatory blockade exacerbates disease severity and accelerates epitope spreading in a virus-induced autoimmune disease.
    Neville KL; Dal Canto MC; Bluestone JA; Miller SD
    J Virol; 2000 Sep; 74(18):8349-57. PubMed ID: 10954534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid promotes the development of Th2-like human myelin basic protein-reactive T cells.
    Lovett-Racke AE; Racke MK
    Cell Immunol; 2002 Jan; 215(1):54-60. PubMed ID: 12142036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis.
    Aharoni R; Teitelbaum D; Sela M; Arnon R
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10821-6. PubMed ID: 9380718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of myelin basic protein-specific helper T cells in multiple sclerosis: generation of suppressor T cell lines.
    Zhang JW; Schreurs M; Medaer R; Raus JC
    Cell Immunol; 1992 Jan; 139(1):118-30. PubMed ID: 1370254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of phosphodiesterase-4 and -3 inhibitors in Th1-mediated autoimmune diseases.
    Bielekova B; Lincoln A; McFarland H; Martin R
    J Immunol; 2000 Jan; 164(2):1117-24. PubMed ID: 10623864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible costimulatory molecule-B7-related protein 1 interactions are important for the clonal expansion and B cell helper functions of naive, Th1, and Th2 T cells.
    Smith KM; Brewer JM; Webb P; Coyle AJ; Gutierrez-Ramos C; Garside P
    J Immunol; 2003 Mar; 170(5):2310-5. PubMed ID: 12594252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
    Tao X; Constant S; Jorritsma P; Bottomly K
    J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation.
    Scholz C; Patton KT; Anderson DE; Freeman GJ; Hafler DA
    J Immunol; 1998 Feb; 160(3):1532-8. PubMed ID: 9570577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine secretion profile of myelin basic protein-specific T cells in multiple sclerosis.
    Rohowsky-Kochan C; Molinaro D; Cook SD
    Mult Scler; 2000 Apr; 6(2):69-77. PubMed ID: 10773850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th Cell Diversity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
    Carbajal KS; Mironova Y; Ulrich-Lewis JT; Kulkarni D; Grifka-Walk HM; Huber AK; Shrager P; Giger RJ; Segal BM
    J Immunol; 2015 Sep; 195(6):2552-9. PubMed ID: 26238492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell response to myelin basic protein before and after treatment with interferon beta in multiple sclerosis.
    Ristori G; Montesperelli C; Gasperini C; Battistini L; Borsellino G; Buttinelli C; Cannoni S; Perna A; Pozzilli C; Salvetti M
    J Neuroimmunol; 1999 Sep; 99(1):91-6. PubMed ID: 10496181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine phenotype of human autoreactive T cell clones specific for the immunodominant myelin basic protein peptide (83-99).
    Hemmer B; Vergelli M; Calabresi P; Huang T; McFarland HF; Martin R
    J Neurosci Res; 1996 Sep; 45(6):852-62. PubMed ID: 8892097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis: comparison of the human T-cell response to S100 beta and myelin basic protein reveals parallels to rat experimental autoimmune panencephalitis.
    Schmidt S; Linington C; Zipp F; Sotgiu S; de Waal Malefyt R; Wekerle H; Hohlfeld R
    Brain; 1997 Aug; 120 ( Pt 8)():1437-45. PubMed ID: 9278633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of B7-2, not B7-1, inhibits purified protein derivative-primed T-lymphocyte responses but fails to influence the proportion of Th1 versus Th2 subsets.
    Shortt J; Hart DN; Watson JD; Baird MA
    Scand J Immunol; 1998 Apr; 47(4):355-62. PubMed ID: 9600317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production.
    Schweitzer AN; Sharpe AH
    J Immunol; 1998 Sep; 161(6):2762-71. PubMed ID: 9743334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.